1. Home
  2. CDLX vs XBIT Comparison

CDLX vs XBIT Comparison

Compare CDLX & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cardlytics Inc.

CDLX

Cardlytics Inc.

HOLD

Current Price

$1.15

Market Cap

69.7M

Sector

Technology

ML Signal

HOLD

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.54

Market Cap

73.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDLX
XBIT
Founded
2008
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
69.7M
73.2M
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
CDLX
XBIT
Price
$1.15
$2.54
Analyst Decision
Hold
Analyst Count
3
0
Target Price
$2.25
N/A
AVG Volume (30 Days)
943.0K
46.4K
Earning Date
03-11-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$251,175,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.85
$2.09
52 Week High
$4.05
$4.00

Technical Indicators

Market Signals
Indicator
CDLX
XBIT
Relative Strength Index (RSI) 44.51 52.40
Support Level $1.21 $2.49
Resistance Level $1.32 $2.64
Average True Range (ATR) 0.12 0.11
MACD -0.00 0.01
Stochastic Oscillator 10.87 60.53

Price Performance

Historical Comparison
CDLX
XBIT

About CDLX Cardlytics Inc.

Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K. and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.

About XBIT XBiotech Inc.

XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.

Share on Social Networks: